Evidence map›Paper›PMID 22649090›Full record

ArticleScience translational medicine2012

SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment.

Dennis J Hartigan-O'Connor, Kristina Abel, Koen K A Van Rompay, Bittoo Kanwar, Joseph M McCune

Abstract read
In one paragraph

Article in Science translational medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. T-Follicular-Like CD8Frontiers in immunology · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Dennis J Hartigan-O'ConnorDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94110, USA. dhartigan@medsfgh.ucsf.edu
Kristina Abel
Koen K A Van Rompay
Bittoo Kanwar
Joseph M McCune
University of California, San Francisco · USUniversity of California, Davis · US

Funding

ZONA PELLUCIDA PEPTIDES AS IMMUNOCONTRACEPTIVE ANTIGENSP51RR000169 · NCRR · UNIVERSITY OF CALIFORNIA DAVIS · PI HYDE, DALLAS MELVIN · 1985 to 2011
$126.2M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
TRAINING PROGRAM IN PEDIATRIC GASTROENTEROLOGY/NUTRITIONT32DK007762 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI James Bayrer · 1998 to 2026
$7.3M
NIH Director's Pioneer Award (RMI)DP1OD000329 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCUNE, JOSEPH M · 2004 to 2008
$4.2M
Studies in Children with Digestive DisordersK24DK060617 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HEYMAN, MELVIN B. · 2002 to 2011
$1.6M
Regulatory T cell influence on infant and adult immune responses to HIVK23AI081540 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HARTIGAN-O'CONNOR, DENNIS J. · 2009 to 2013
$724k
Role of type I interferons in mucosal anti-SIV immunityR21DE016541 · NIDCR · UNIVERSITY OF CALIFORNIA DAVIS · PI ABEL, KRISTINA · 2004 to 2005
$413k
Analysis of Immune Responses in Inflammatory Bowel Disease by Immuno-PETK08DK083334 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KANWAR, BITTOO · 2010 to 2011
$290k
Impact of T-regulatory cells on SIV disease progressionF32AI067088 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HARTIGAN-O'CONNOR, DENNIS J. · 2005 to 2008
$150k
NCRR NIH HHS P51 RR000169NCRR NIH HHS RR-00169NIAID NIH HHS F32 AI067088NIAID NIH HHS K23 AI081540NIAID NIH HHS P30 AI027763NIDCR NIH HHS R21 DE016541NIDDK NIH HHS K08 DK083334NIDDK NIH HHS K08 DK83334NIDDK NIH HHS K24 DK060617NIDDK NIH HHS T32 DK007762NIH HHS DP1 OD000329NIH HHS OD000329PHS HHS DPIOD00329
6 · The paper itself

Abstract

The mechanisms by which some HIV-infected subjects resist disease progression, whereas others progress rapidly, are incompletely understood. Viral and host genetic factors, such as nef deletions and major histocompatibility complex alleles, explain a portion of the observed variability. However, it has been difficult to identify host immune functions that may be present before infection and that allow resistance to lentiviral disease progression. Here, we show that simian immunodeficiency virus replication in the infected rhesus macaque is limited by the size of the preexisting T helper 17 (T(H)17) cell compartment: Animals with a high representation of such cells in blood and intestinal tissue before infection experienced peak and set-point viral loads about one log unit lower than those with a lower representation of T(H)17 cells. Reciprocally, treatment of macaques with interleukin-2 and granulocyte colony-stimulating factor before infection led to depletion of T(H)17 cells, reduction of the ratio between T(H)17 cells and CD3(+)CD4(+)CD25(+)CD127(low) regulatory T cells, and higher viral loads for 6 months after infection. These results demonstrate that the composition of the host immune system before infection has an influence on the course of disease after infection. Furthermore, to the extent that this influence shapes and interacts with T cell-mediated responses to virus, our findings provide a new framework for understanding interindividual variation in responses to therapies and vaccines against HIV.

Indexed as

AnimalsMacaca mulattaSimian Immunodeficiency VirusTh17 CellsVirus Replication

Identifiers

PMID22649090
PMCPMC3520607
OpenAlexW2003152924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.